Temodal and white blood cell count decreased Patient Reports February 12, 2012

Temodal Side Effects Report #5494424-1
Temodal side effect was reported by a Physician from JAPAN on Oct 18, 2007. Male patient, 48 years of age, weighting 105.8 lb, was diagnosed with oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood glucose increased, blood sodium decreased, disseminated intravascular coagulation, neoplasm progression, pneumonia , white blood cell count decreased. Temodal dosage: PO, 200 MG/M2; QD; PO, 200 MG/M2; QD; PO, 200 MG/M2; QD; PO. During the same period patient was treated with BAKTAR, ZOFRAN, PRIMPERAN, LENDORMIN D, EXCEGRAN. Patient died on 03/06/2007.

Temodal Side Effects Report #5818358-5
Temodal side effect was reported by a Physician from JAPAN on July 15, 2008. Male patient, 48 years of age, weighting 105.8 lb, was diagnosed with oligodendroglioma, disease recurrence and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood glucose increased, blood sodium decreased, disease progression, disseminated intravascular coagulation, pneumonia , white blood cell count decreased. Temodal dosage: PO; 200 MG/M2; QD; PO. During the same period patient was treated with COTRIM, ZOFRAN, PRIMPERAN, LENDORMIN D, EXCEGRAN. Patient died on 03/06/2007.

Temodal Side Effects Report #5354597-8
Temodal side effect was reported by a Physician from JAPAN on May 24, 2007. Male patient, 48 years of age, weighting 105.8 lb, was diagnosed with neoplasm recurrence, oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood glucose increased, blood sodium decreased, platelet count decreased, white blood cell count decreased. Temodal dosage: unknown. During the same period patient was treated with BAKTAR. Patient died on 03/06/2007.

Temodal Side Effects Report #4844923-8
Temodal side effect was reported by a Physician from NORWAY on Nov 17, 2005. Female patient, 65 years of age, was diagnosed with neoplasm malignant and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, white blood cell count decreased. Temodal dosage: 120 MG ORAL. Patient died.


Temodal Side Effects Report #4852951-1
Temodal side effect was reported by a Physician from NORWAY on Dec 01, 2005. Female patient, 65 years of age, was diagnosed with mixed oligo-astrocytoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: fall , haemoglobin decreased, head injury, intracranial tumour haemorrhage, platelet count decreased, unevaluable event, white blood cell count decreased. Temodal dosage: 140 MG QD ORAL. During the same period patient was treated with WARFARIN, MEDROL, NEXIUM, TRIMONIL. Patient died on 10/21/2005.

Temodal Side Effects Report #5441511-X
Temodal side effect was reported by a Physician from JAPAN on Aug 21, 2007. Male patient, child 8 years of age, weighting 44.09 lb, was diagnosed with medulloblastoma recurrent and was treated with Temodal. After drug was administered, patient experienced the following side effects: hypogammaglobulinaemia, lymphocyte count decreased, white blood cell count decreased. Temodal dosage: 200 MG/M2; QD; PO, 200 MG/M2; QD; PO, 200 MG/M2; QD; PO, 200 MG/M2; QD; PO, 200 MG/M2; QD; PO. During the same period patient was treated with ETOPOSIDE, BAKTAR, SELENICA, MUCODYNE. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5995372-0
Temodal side effect was reported by a Physician from JAPAN on Dec 05, 2008. Male patient, child 8 years of age, weighting 44.09 lb, was diagnosed with medulloblastoma recurrent and was treated with Temodal. After drug was administered, patient experienced the following side effects: hypogammaglobulinaemia, lymphocyte count decreased, neutrophil count decreased, white blood cell count decreased. Temodal dosage: 200 MG/M2; QD; PO. During the same period patient was treated with ETOPOSIDE, BAKTAR, SELENICA, MUCODYNE. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5548332-8
Temodal side effect was reported by a Physician from JAPAN on Dec 03, 2007. Male patient, 63 years of age, weighting 156.5 lb, was diagnosed with malignant oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: convulsion, disease progression, myelodysplastic syndrome, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Temodal dosage: PO; 200 MG/M2; QD; PO150 MG/M2; QD; PO. During the same period patient was treated with DEPAKENE. Patient was hospitalized. Patient died on 11/27/2007.

Temodal Side Effects Report #6104267-3
Temodal side effect was reported by a Physician from JAPAN on Feb 24, 2009. Female patient, 80 years of age, weighting 88.18 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: dehydration, interstitial lung disease, malignant neoplasm progression, white blood cell count decreased. Temodal dosage: unknown. Patient was hospitalized. Patient died on 08/18/2008.


Temodal Side Effects Report #5483226-8
Temodal side effect was reported by a Physician from JAPAN on Oct 03, 2007. Female patient, 79 years of age, weighting 105.8 lb, was diagnosed with glioblastoma multiforme, convulsion and was treated with Temodal. After drug was administered, patient experienced the following side effects: glioblastoma multiforme, hepatic function abnormal, malignant neoplasm progression, neutrophil count decreased, white blood cell count decreased. Temodal dosage: 75 MG/M2; QD; PO; 150 MG/M2;QD;PO; 150 MG/M2;QD;PO; 150 MG/M2;QD;PO 150 MG/M2;QD;PO 150 MG/M2;QD;PO. During the same period patient was treated with DEPAKENE, SEROQUEL, NAVOBAN. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5739564-4
Temodal side effect was reported by a Physician from JAPAN on May 08, 2008. Female patient, 79 years of age, weighting 105.8 lb, was diagnosed with glioblastoma multiforme, convulsion and was treated with Temodal. After drug was administered, patient experienced the following side effects: hepatic function abnormal, metastases to central nervous system, neoplasm progression, neutrophil count decreased, white blood cell count decreased. Temodal dosage: unknown. During the same period patient was treated with DEPAKENE, SEROQUEL, NAVOBAN. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5236365-0
Temodal side effect was reported by a Physician from JAPAN on Feb 05, 2007. Male patient, 77 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: infection , platelet count decreased, white blood cell count decreased. Temodal dosage: 140 MG; QD; PO. During the same period patient was treated with FERON. Patient died on 01/30/2007.

Temodal Side Effects Report #5248553-8
Temodal side effect was reported by a Physician from JAPAN on Feb 19, 2007. Male patient, 77 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, sepsis , white blood cell count decreased. Temodal dosage: 140 MG;QD;PO. During the same period patient was treated with FERON. Patient died on 01/30/2007.

Temodal Side Effects Report #5483255-4
Temodal side effect was reported by a Physician from JAPAN on Oct 01, 2007. Male patient, 77 years of age, weighting 165.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood urea increased, c-reactive protein increased, platelet count decreased, red blood cell count decreased, sepsis , white blood cell count decreased. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with FERON, MUCOSTA, FAMOTIDINE, PRAVASTATIN, AMLODIPINE, EXCEGRAN, GLYCYRON. Patient died on 01/30/2007.


Temodal Side Effects Report #5570153-0
Temodal side effect was reported by a Physician from JAPAN on Dec 13, 2007. Female patient, 65 years of age, weighting 121.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: altered state of consciousness, brain oedema, disseminated intravascular coagulation, pulmonary embolism , pulmonary infarction, white blood cell count decreased. Temodal dosage: 75 MG/M2; QD; PO; 150 MG/M2; QD; PO. During the same period patient was treated with DECADRON, BAKTAR, GLYCEOL, LOXONIN. Patient was hospitalized. Patient died on 01/30/2007.

Temodal Side Effects Report #5429903-6
Temodal side effect was reported by a Physician from JAPAN on Aug 21, 2007. Male patient, 63 years of age, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, lung disorder, platelet count decreased, pneumonia , respiratory failure, shock, white blood cell count decreased. Temodal dosage: 250 MG; QD; PO, 250 MG; QD; PO, 150 MG/M2; QD; PO. During the same period patient was treated with FERON, CYMERIN, TEGRETOL, EXCEGRAN, PENTCILLIN, SULPERAZON. Patient died on 10/14/2006.

Temodal Side Effects Report #5776555-1
Temodal side effect was reported by a Physician from JAPAN on June 11, 2008. Male patient, 60 years of age, weighting 147.7 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood pressure diastolic decreased, disease progression, disseminated intravascular coagulation, platelet count decreased, pneumonia aspiration, sepsis , vomiting, white blood cell count decreased. Temodal dosage: 150 MG/M2;QD;PO; 100 MG/M2;QD;PO. During the same period patient was treated with EXCEGRAN, SELENICA, FAMOTIDINE, MYSTAN. Patient died on 05/14/2008.

Temodal Side Effects Report #6104001-7
Temodal side effect was reported by a Physician from JAPAN on Feb 24, 2009. Female patient, 57 years of age, weighting 147.7 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: dysphagia, leukoencephalopathy, nausea , neutrophil count decreased, pneumonia , white blood cell count decreased. Temodal dosage: unknown. During the same period patient was treated with BAKTAR, DEPAKENE, EXCEGRAN, LIPITOR. Patient died on 01/20/2009.

Temodal Side Effects Report #5196360-7
Temodal side effect was reported by a Physician from JAPAN on Dec 15, 2006. Female patient, 56 years of age, weighting 110.2 lb, was diagnosed with glioblastoma multiforme, epilepsy , gastric ulcer, gastritis and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, stevens-johnson syndrome, white blood cell count decreased. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with ZONEGRAN, FAMOTIDINE, ISOBIDE, DECADRON, ZOFRAN, TOUGHMAC E. Patient was hospitalized. Patient recovered.


Temodal Side Effects Report #5804112-7
Temodal side effect was reported by a Physician from JAPAN on July 01, 2008. Female patient, 56 years of age, weighting 110.2 lb, was diagnosed with glioblastoma multiforme, epilepsy , gastric ulcer, gastritis and was treated with Temodal. After drug was administered, patient experienced the following side effects: lymphocyte count decreased, platelet count decreased, refusal of treatment by patient, stevens-johnson syndrome, white blood cell count decreased. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with ZONISAMIDE, FAMOTIDINE, ISOBIDE, DECADRON, ZOFRAN, TOUGHMAC E. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5931896-X
Temodal side effect was reported by a Consumer or non-health professional from JAPAN on Oct 17, 2008. Female patient, 56 years of age, weighting 110.2 lb, was diagnosed with glioblastoma multiforme, epilepsy , gastric ulcer, gastritis and was treated with Temodal. After drug was administered, patient experienced the following side effects: lymphocyte count decreased, pain , platelet count decreased, stevens-johnson syndrome, white blood cell count decreased. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with ZONISAMIDE, FAMOTIDINE, ISOBIDE, DECADRON, ZOFRAN, TOUGHMAC E. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5273335-0
Temodal side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Mar 08, 2007. Male patient, 52 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: prescribed overdose, sepsis , white blood cell count decreased. Temodal dosage: 150 MG/M2. Patient died on 03/07/2007.

Temodal Side Effects Report #5967985-3
Temodal side effect was reported by a Physician from JAPAN on Nov 19, 2008. Male patient, 47 years of age, weighting 165.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: c-reactive protein increased, disease progression, immunosuppression, nasopharyngitis, pneumocystis jiroveci pneumonia, pulmonary fibrosis , white blood cell count decreased. Temodal dosage: 75 MG/M2; QD, PO. During the same period patient was treated with TEGRETOL, GLYCEOL, CELESTONE, FAMOTIDINE, ZOFRAN, MENILET, ACHROMYCIN, ALESION. Patient died on 03/29/2007.

Temodal Side Effects Report #5500156-3
Temodal side effect was reported by a Physician from JAPAN on Oct 18, 2007. Male patient, weighting 105.8 lb, was diagnosed with glioblastoma multiforme, recurrent cancer and was treated with Temodal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, white blood cell count decreased. Temodal dosage: 150 MG/M2; QD; PO, 150 MG/M2; QD; PO, 150 MG/M2; QD; PO, 150 MG/M2; QD; PO, 150 MG/M2; QD; PO. Patient recovered.


Temodal Side Effects Report #5742524-0
Temodal side effect was reported by a Physician from JAPAN on May 09, 2008. Male patient, weighting 105.8 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, white blood cell count decreased. Temodal dosage: 150 MG/M2; QD; PO. During the same period patient was treated with BAKTAR, FAMOTIDINE, CEPHADOL, NAUZELIN. Patient recovered.

Temodal Side Effects Report #5917665-5
Temodal side effect was reported by a Consumer or non-health professional from JAPAN on Oct 08, 2008. Male patient, 74 years of age, weighting 138.9 lb, was diagnosed with glioblastoma, convulsion prophylaxis and was treated with Temodal. After drug was administered, patient experienced the following side effects: anaemia, bone marrow failure, glioblastoma, leukopenia, pyrexia, thrombocytopenia, tumour haemorrhage, white blood cell count decreased. Temodal dosage: 120 MG; QD; PO. During the same period patient was treated with ZONISAMIDE, NORVASC, BLOPRESS, MAGMITT, COTRIM. Patient was hospitalized. Patient died on 05/10/2008.

Temodal Side Effects Report #5090752-2
Temodal side effect was reported by a Physician from FRANCE on Aug 16, 2006. Male patient, 68 years of age, weighting 154.3 lb, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: agranulocytosis, aplasia, immunosuppression, malaise, pneumocystis jiroveci pneumonia, pyrexia, white blood cell count decreased. Temodal dosage: 140 MG QD ORAL. During the same period patient was treated with DEPAKENE, OMEPRAZOLE, MEDROL, SOLUPRED. Patient was hospitalized. Patient died on 08/09/2006.

Temodal Side Effects Report #5758856-6
Temodal side effect was reported by a Physician from AUSTRIA on May 28, 2008. Female patient, 64 years of age, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: haemorrhage, neoplasm progression, somnolence, thrombocytopenia, tumour necrosis, white blood cell count decreased. Temodal dosage: unknown. During the same period patient was treated with OMEPRAZOLE, FORTECORTIN, KEPPRA, FRISIUM, NORVASC, MOXONIBENE, SEREVENT, FLIXOTIDE. Patient was hospitalized. Patient died on 05/09/2008.

Temodal Side Effects Report #5766838-3
Temodal side effect was reported by a Physician from AUSTRIA on June 05, 2008. Female patient, 64 years of age, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: haemorrhage, neoplasm progression, somnolence, thrombocytopenia, tumour necrosis, white blood cell count decreased. Temodal dosage: unknown. During the same period patient was treated with OMEPRAZOLE, FORTECORTIN, KEPPRA, FRISIUM, NORVASC, MOXONIBENE, SEREVENT, FLIXOTIDE. Patient was hospitalized. Patient died on 05/09/2008.


Temodal Side Effects Report #4621129-9
Temodal side effect was reported by a Physician from on Mar 16, 2005. Male patient was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: epistaxis, haemoglobin decreased, thrombocytopenia, white blood cell count decreased. Temodal dosage: 75 MG/M2 QD ORAL. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5186501-X
Temodal side effect was reported by a Physician from JAPAN on Dec 07, 2006. Female patient, 56 years of age, weighting 110.2 lb, was diagnosed with epilepsy , prophylaxis and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, refusal of treatment by patient, stevens-johnson syndrome, white blood cell count decreased. Temodal dosage: 200 MG; PO. During the same period patient was treated with ZONEGRAN, ISOBIDE, DECADRON, ZOFRAN, TOUGHMAC E, GASTER D. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5521656-6
Temodal side effect was reported by a Physician from JAPAN on Nov 08, 2007. Female patient, 71 years of age, weighting 114.6 lb, was diagnosed with ependymoma malignant and was treated with Temodal. After drug was administered, patient experienced the following side effects: hepatic function abnormal, hydronephrosis, liver function test abnormal, platelet count decreased, pyelonephritis, urinary tract infection , white blood cell count decreased. Temodal dosage: 120 MG; QD; PO. During the same period patient was treated with PREDONINE, ONEALFA, GLAKAY, FOSAMAC, TAKEPRON OD, FASTIC. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5574105-6
Temodal side effect was reported by a Physician from JAPAN on Dec 18, 2007. Female patient, 71 years of age, weighting 114.6 lb, was diagnosed with ependymoma malignant and was treated with Temodal. After drug was administered, patient experienced the following side effects: hepatic function abnormal, hydronephrosis, platelet count decreased, pyelonephritis, pyrexia, urinary tract infection , white blood cell count decreased. Temodal dosage: 120 MG; QD; PO. During the same period patient was treated with PREDONINE, ONEALFA, GLAKAY, FOSAMAC, TAKEPRON OD, FASTIC. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5574105-6
Temodal side effect was reported by a Physician from JAPAN on Dec 18, 2007. Female patient, 71 years of age, weighting 114.6 lb, was diagnosed with ependymoma malignant and was treated with Temodal. After drug was administered, patient experienced the following side effects: hepatic function abnormal, hydronephrosis, platelet count decreased, pyelonephritis, urinary tract infection , white blood cell count decreased. Temodal dosage: 120 MG; QD; PO. During the same period patient was treated with PREDONINE, ONEALFA, GLAKAY, FOSAMAC, TAKEPRON OD, FASTIC. Patient was hospitalized. Patient recovered.


Temodal Side Effects Report #5567364-7
Temodal side effect was reported by a Physician from JAPAN on Dec 07, 2007. Male patient, 60 years of age, weighting 147.7 lb, was diagnosed with disease recurrence, glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, neoplasm progression, pneumonia aspiration, sepsis , vomiting, white blood cell count decreased. Temodal dosage: 15 MG/M2; QD; PO; 100 MG/M2; QD; PO; 150 MG/M2; QD; PO; 150 MG/M2; PO. During the same period patient was treated with EXCEGRAN. Patient recovered.

Temodal Side Effects Report #5494552-0
Temodal side effect was reported by a Physician from JAPAN on Oct 16, 2007. Female patient, 71 years of age, weighting 114.6 lb, was diagnosed with brain neoplasm and was treated with Temodal. After drug was administered, patient experienced the following side effects: hepatic function abnormal, white blood cell count decreased. Temodal dosage: 75 MG/MG; QD; PO. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5261487-8
Temodal side effect was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, child 6 years of age, weighting 35.27 lb, was diagnosed with brain neoplasm and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood urea increased, brain neoplasm, disease progression, hypernatraemia, platelet count decreased, pneumonia bacterial, tumour necrosis, white blood cell count decreased. Temodal dosage: 75 MG/M2;QD;PO. During the same period patient was treated with VEPESID, BAKTAR, LASTET S, NASEA, PRIMPERAN, DECADRON, MANNITOL, LEPETAN. Patient died on 10/26/2006.

Temodal Side Effects Report #5757741-3
Temodal side effect was reported by a Physician from JAPAN on May 27, 2008. Female patient, 52 years of age, weighting 94.80 lb, was diagnosed with astrocytoma, neoplasm recurrence and was treated with Temodal. After drug was administered, patient experienced the following side effects: cerebellar ataxia, insomnia, neoplasm progression, neoplasm recurrence, neutrophil count decreased, platelet count decreased, restlessness, white blood cell count decreased. Temodal dosage: PO; 200 MG/M2; QD; PO. Patient was hospitalized. Patient died on 01/07/2008.

Temodal Side Effects Report #5859214-6
Temodal side effect was reported by a Health Professional from CANADA on Aug 20, 2008. Female patient, 30 years of age, was diagnosed with astrocytoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: contusion, convulsion, gingival bleeding, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Temodal dosage: 350 MG/M2; QD; PO. Patient was hospitalized. Patient died on 08/10/2008.


Temodal Side Effects Report #5835897-1
Temodal side effect was reported by a Physician from JAPAN on July 31, 2008. Male patient, 56 years of age, weighting 116.8 lb, was diagnosed with anaplastic astrocytoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: altered state of consciousness, c-reactive protein increased, disease progression, lymphocyte count decreased, pneumonia , white blood cell count decreased. Temodal dosage: PO, 200 MG/M2; QD; PO. Patient was hospitalized. Patient died on 01/01/2008.

Temodal Side Effects Report #6059400-9
Temodal side effect was reported by a Pharmacist from CANADA on Jan 26, 2009. Female patient was treated with Temodal. After drug was administered, patient experienced the following side effects: hepatic enzyme increased, neutropenia, overdose, white blood cell count decreased. Temodal dosage: 200 MG/M2; PO. Patient was hospitalized. Patient recovered.